Filter trials by:

Year

Indication

Phase

Type

Indication: Psoriatic Arthritis

A Phase 3, Randomized, Double blind, Placebo controlled Study to Evaluate the Efficacy and Safety of Filgotinib in Subjects with Active Psoriatic Arthritis Who Have an Inadequate Response or are Intolerant to Biologic DMARD Therapy.

Year: 2020
Type: Musculoskeletal
Phase: III
Indication: Psoriatic Arthritis

A Phase 3, Randomized, Double-blind, Placebo and Adalimumab-controlled Study to Evaluate the Efficacy and Safety of Filgotinib in Subjects with Active Psoriatic Arthritis Who Are Naïve to Biologic DMARD Therapy.

Year: 2020
Type: Musculoskeletal
Phase: III
Indication: Psoriatic Arthritis